why choose us

First received: September 06, 2023

Clinical Trial: Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Low Grade Glioma

Study Type: INTERVENTIONAL


Official Title: Post-Operative Dosing of Steroids Post Craniotomy for Brain Tumor (PODS)

Brief Summary: This phase II trial tests the effect of decreasing (tapering) doses of dexamethasone on steroid side effects in patients after surgery to remove (craniotomy) a brain tumor.Steroids are the gold standard post-surgery treatment to reduce swelling (edema) at the surgical site to reduce neurological symptoms.Although, corticosteroids reduce edema, they have side effects including high blood sugar, high blood pressure, and can impair wound healing.Dexamethasone is in a class of medications called corticosteroids.It is…

Read more